APOA1 and neoplasm: Our previous studies demonstrated that apoA-I, apoJ and apoE mimetic peptides inhibit tumor development in mouse models of ovarian and colon cancer [17–21], and play an important anti-atherogenic role in facilitating the clearance of LDL from the circulation [22].